NuVasive loses 2nd, $30M trademark trial against NeuroVision

April 4, 2014 by Brad Perriello

NuVasive pledges to appeal a $30 million loss in a trademark infringement lawsuit leveled against it by NeuroVision Medical Products, the 2nd time a court found against NuVasive.

NuVasive loses 2nd, $30M trademark trial against NeuroVision

NuVasive Inc. (NSDQ:NUVA) vowed to appeal its 2nd loss to NeuroVision Medical Products in a trademark infringement lawsuit, after a California jury yesterday awarded $30 million in damages to NeuroVision.

NeuroVision 1st sued NuVasive in 2009, alleging infringement of its namesake trademark.


Read the rest here

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *